Exercise Training to Lose Weight in Obese Asthmatics
Primary Purpose
Asthma, Obesity
Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Dietary
Education Program
Behavioral Therapy
Exercise Training
Stretching and Breathing exercise
Sponsored by

About this trial
This is an interventional treatment trial for Asthma focused on measuring Asthma, Obesity, Clinical control, Exercise, Weight-loss
Eligibility Criteria
Inclusion Criteria:
- Asthma moderate and severe
- Asthma will diagnosed (Global Initiative for Asthma -GINA)
- Body Mass Index between 35 kg/ m2 and 39,9 kg/m2
- Sedentary
- Medical treatment, for at least 6 months
- Clinically stable (i.e., no exacerbation or medication changes for at least 30 days)
Exclusion Criteria:
- Cardiovascular, musculoskeletal or other chronic lung diseases
- Active Cancer
- Pregnant
- Weight loss more than 5 % in the preceding 6 months
- Using weight-loss medications
- History of bariatric surgery, uncontrolled hypertension or diabetes
- Using overnight continuous positive airway pressure
- Lactating
- Current or ex-smoker
Sites / Locations
- Clinical Hospital of São Paulo University medical school (HCFMUSP)
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
Exercise, dietary and behavioral therapy
Dietary and behavioral therapy
Arm Description
The interventions of active comparator will be education program, dietary and behavioral therapy and exercise training.
The intervention in sham comparator will be education program, dietary and behavioral therapy and stretching and breathing exercise.
Outcomes
Primary Outcome Measures
Clinical Control
Clinical control will be evaluated by asthma control questionnaire (ACQ)
Secondary Outcome Measures
Health related quality of life
Health related quality of life will be assessed by Asthma Quality Life Questionnaire (AQLQ)
Level of depression and anxiety
the symptoms of depression and anxiety will be assessed by Hospital Anxiety and Depression (HAD)
Full Information
NCT ID
NCT02188940
First Posted
July 10, 2014
Last Updated
February 19, 2016
Sponsor
University of Sao Paulo General Hospital
Collaborators
University of Sao Paulo, Fundação de Amparo à Pesquisa do Estado de São Paulo
1. Study Identification
Unique Protocol Identification Number
NCT02188940
Brief Title
Exercise Training to Lose Weight in Obese Asthmatics
Official Title
Effects of Exercise Training in a Weight-loss Lifestyle Intervention on Clinical Control and Psychosocial Morbidity in Obese Asthmatics: a Randomized and Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2014
Overall Recruitment Status
Completed
Study Start Date
July 2014 (undefined)
Primary Completion Date
February 2015 (Actual)
Study Completion Date
October 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Sao Paulo General Hospital
Collaborators
University of Sao Paulo, Fundação de Amparo à Pesquisa do Estado de São Paulo
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Obese asthmatics have more severe symptoms, reduced lung function, poorer quality of life and a reduced response to inhaled corticosteroid medication compared to non-obese asthmatics. In addition, the impact of a weight-loss program on clinical control and psychological outcomes has been poorly demonstrated and the effect of exercise training remain unknown. The investigators aim to investigate the effect of exercise training in a weight-loss program on asthma clinical control (primary outcome), health factors related to quality of life and psychosocial symptoms (secondary outcomes) in obese patients with moderate-to-severe persistent asthma. Physical activity, inflammatory profiles and sleep disorders will also be evaluated. The investigators' hypothesis is that exercise as part of a weight-loss program is more effective to lose weight and improve asthma control, quality of life and psychosocial symptoms in obese asthmatics.
Detailed Description
This is a randomized, controlled and single blinded trial. Fifty-four asthmatic adults will be randomly assigned into two groups: DBG (dietary and behavioral support group) or DBE (similar to DBG + exercise training). Both groups will complete a weight-loss program based on dietary and behavioral therapy. In addition, DBE will perform a training program based on aerobic and resistance training whereas DBG will perform a breathing and stretching program. Interventions will be performed twice a week for 3 months, 60 minutes each. The data normality will be analyzed by Kolmogorov-Smirnov, the variables obtained before interventions will be compared with the Student t-test or Mann-whitney U-test. Comparisons of the initial and final data on outcomes will be analyzed with repeated measures ANOVA with appropriate post hoc of Bonferroni. The significance level will be set to 5% for all tests.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma, Obesity
Keywords
Asthma, Obesity, Clinical control, Exercise, Weight-loss
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
55 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Exercise, dietary and behavioral therapy
Arm Type
Active Comparator
Arm Description
The interventions of active comparator will be education program, dietary and behavioral therapy and exercise training.
Arm Title
Dietary and behavioral therapy
Arm Type
Sham Comparator
Arm Description
The intervention in sham comparator will be education program, dietary and behavioral therapy and stretching and breathing exercise.
Intervention Type
Behavioral
Intervention Name(s)
Dietary
Intervention Description
The dietary therapy will be performed every 15 days, totaling 6 sessions of 60 minutes each by a dietitian. Patients will be advised to follow restricted-calorie diet based on the hypocaloric dietary guidance, multiplying the patient's weight by 20 to 25 calories. The Nutwin ® program will be used to structure the patient's diets, based on 24 hours food record and calories tables. Throughout the program, issues related to food control, the benefits of following a balanced diet and the changing food habits will be discussed.
Intervention Type
Behavioral
Intervention Name(s)
Education Program
Intervention Description
The education program will consist of 4 classes lasting 6 hours at the beginning of the interventions, in which issues related to asthma and physical activity will be discussed. Presentations and group discussions will be carried out, including information about asthma pathophysiology, medication and peakflowmeter skills, self-monitoring techniques, environmental control, benefits and current recommendations of physical activity.
Intervention Type
Behavioral
Intervention Name(s)
Behavioral Therapy
Intervention Description
The Behavioral therapy will be performed every 15 days, totaling 6 sessions of 60 minutes each by a psychologist. Sessions of group dynamics will be performed to increase the patient adherence in a weight loss program using behavior modification techniques, such as self-management, motivational strategies, positive reinforcement and relapse prevention. Relaxation techniques, experiences and patient's report will also be used.
Intervention Type
Other
Intervention Name(s)
Exercise Training
Intervention Description
The aerobic training will be performed on a treadmill and a bike (or an elliptical), twice a week, totaling 24 sessions of 60 minutes each. The initial intensity will be 50% to 60% of VO2 max reaching a maximal 75% of VO2 max and the progression will take place according to the level of effort (Borg) in the last two sessions. Patients will be advised to walk outside at least twice a week for 30 minutes and write down their activity in a diary. Furthermore, they will be given an accelerometer in week 6 to record their daily steps. The resistance training will consist of exercises for the upper and lower limbs. Initially, the patients will perform 2 sets of 10 repetitions with load of 50% to 70% of 1-RM and the progression will take place in the number of repetition, and then in the load.
Intervention Type
Other
Intervention Name(s)
Stretching and Breathing exercise
Intervention Description
Breathing exercise will consist of 3 exercises adapted from yoga's breathing technique (kapalabhati, uddhiyana and agnisara) twice a week, totaling 24 sessions of 30 minutes each. Every exercise will be performed in sets of 3 (2 minutes each) with 60 seconds of rest between them. The stretching will consist of stretching exercises for the major muscle groups in 3 sets of 10 seconds each. The program will be performed twice a week, totaling 24 sessions of 30 minutes each.
*Both breathing and stretching exercises will be performed as placebo to ensure the same duration of treatment between the two groups.
Primary Outcome Measure Information:
Title
Clinical Control
Description
Clinical control will be evaluated by asthma control questionnaire (ACQ)
Time Frame
Before and after 3 months of intervention
Secondary Outcome Measure Information:
Title
Health related quality of life
Description
Health related quality of life will be assessed by Asthma Quality Life Questionnaire (AQLQ)
Time Frame
Before and after 3 months of intervention
Title
Level of depression and anxiety
Description
the symptoms of depression and anxiety will be assessed by Hospital Anxiety and Depression (HAD)
Time Frame
Before and after 3 months of intervention
Other Pre-specified Outcome Measures:
Title
Airway inflammation
Description
Airway inflammation will be quantified using the exhaled fraction of nitric oxide (FeNO)
Time Frame
Before and after 3 months of intervention
Title
serum cytokines and adipokines levels
Description
The method Cytometric Beat Array (CBA) (BD Biosciences, USA) will be used to analyze the levels of interleukins (IL) IL-4, IL-5, IL-6, IL-8, IL -10,IL-1ra, IL-13,Tumor Necrosis Factor (TNF-α), leptin, adiponectin and C-reactive protein (CRP)
Time Frame
Before and after 3 months of intervention
Title
Daily life physical activity
Description
Daily life physical activity will be assessed using an accelerometer (actigraph activity monitor) and physical capacity will be assessed by an incremental cardiopulmonary exercise testing
Time Frame
Before and after 3 months of intervention
Title
Sleep disorders
Description
sleep disorders will be assessed by Berlin Questionnaire for Sleep Apnea and Actisleep activity monitor
Time Frame
Before and after 3 months of intervention
Title
Lung function
Description
Static and dynamic lung volumes will be assessed by Spirometry and Plethysmograph
Time Frame
Before and after 3 months of intervention
Title
Physical fitness
Description
Aerobic potency will be assessed by Cardiopulmonary exercise test
Time Frame
Before and after 3 months of intervention
Title
Asthma symptoms and exacerbations
Description
Asthma symptoms will be assessed using a daily diary of symptoms and exacerbation will be defined by an increase in symptoms associated with at least one of the following criteria: use of rescue medication ≥4 puffs per 24 hours during a 48-hour period, need for systemic corticosteroids, unscheduled medical appointment, visit to an emergency room or hospitalization.
Time Frame
Before and after 3 months of intervention
Title
Body composition
Description
Body composition will be analyzed by using a tetrapolar 8-point tactile bioelectrical impedance
Time Frame
Before and after 3 months of intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Asthma moderate and severe
Asthma will diagnosed (Global Initiative for Asthma -GINA)
Body Mass Index between 35 kg/ m2 and 39,9 kg/m2
Sedentary
Medical treatment, for at least 6 months
Clinically stable (i.e., no exacerbation or medication changes for at least 30 days)
Exclusion Criteria:
Cardiovascular, musculoskeletal or other chronic lung diseases
Active Cancer
Pregnant
Weight loss more than 5 % in the preceding 6 months
Using weight-loss medications
History of bariatric surgery, uncontrolled hypertension or diabetes
Using overnight continuous positive airway pressure
Lactating
Current or ex-smoker
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Celso RF Carvalho, PhD
Organizational Affiliation
University of Sao Paulo General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinical Hospital of São Paulo University medical school (HCFMUSP)
City
São Paulo
ZIP/Postal Code
05360-160
Country
Brazil
12. IPD Sharing Statement
Plan to Share IPD
Yes
Citations:
PubMed Identifier
27744739
Citation
Freitas PD, Ferreira PG, Silva AG, Stelmach R, Carvalho-Pinto RM, Fernandes FL, Mancini MC, Sato MN, Martins MA, Carvalho CR. The Role of Exercise in a Weight-Loss Program on Clinical Control in Obese Adults with Asthma. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2017 Jan 1;195(1):32-42. doi: 10.1164/rccm.201603-0446OC.
Results Reference
derived
PubMed Identifier
26487563
Citation
Freitas PD, Ferreira PG, da Silva A, Trecco S, Stelmach R, Cukier A, Carvalho-Pinto R, Salge JM, Fernandes FL, Mancini MC, Martins MA, Carvalho CR. The effects of exercise training in a weight loss lifestyle intervention on asthma control, quality of life and psychosocial symptoms in adult obese asthmatics: protocol of a randomized controlled trial. BMC Pulm Med. 2015 Oct 21;15:124. doi: 10.1186/s12890-015-0111-2.
Results Reference
derived
Learn more about this trial
Exercise Training to Lose Weight in Obese Asthmatics
We'll reach out to this number within 24 hrs